Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Cokgor

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
North Carolina Medical Journal|May 27, 1999
Seizures and Creutzfeldt-Jakob disease. A case report and series reviewI Cokgor, M Rozear, J C Morgenlander
Cancer Investigation|May 4, 1999
Chemotherapy for adults with malignant gliomaI Cokgor, H S Friedman, A H Friedman
Optics Letters|October 6, 2009
Distributed opticalfiber sensor for spatial location of mode coupling by using the optical Kerr effectI Cokgor, V A Handerek, A J Rogers
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
GliomasI Cokgor, A H Friedman, H S Friedman
Cancer Metastasis Reviews|June 16, 2000
Monoclonal antibody therapy of human gliomas: current status and future approachesC J Wikstrand, I Cokgor, J H Sampson, et al.
Cancer|March 26, 1999
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at DukeH S Friedman, T Kerby, S Fields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumorsG Akabani, C J Reist, I Cokgor, et al.
Cancer|May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case studyI Cokgor, G Akabani, H S Friedman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapyG Akabani, I Cokgor, R E Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
North Carolina Medical Journal|May 27, 1999
Seizures and Creutzfeldt-Jakob disease. A case report and series reviewI Cokgor, M Rozear, J C Morgenlander
Cancer Investigation|May 4, 1999
Chemotherapy for adults with malignant gliomaI Cokgor, H S Friedman, A H Friedman
Optics Letters|October 6, 2009
Distributed opticalfiber sensor for spatial location of mode coupling by using the optical Kerr effectI Cokgor, V A Handerek, A J Rogers
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
GliomasI Cokgor, A H Friedman, H S Friedman
Cancer Metastasis Reviews|June 16, 2000
Monoclonal antibody therapy of human gliomas: current status and future approachesC J Wikstrand, I Cokgor, J H Sampson, et al.
Cancer|March 26, 1999
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at DukeH S Friedman, T Kerby, S Fields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumorsG Akabani, C J Reist, I Cokgor, et al.
Cancer|May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case studyI Cokgor, G Akabani, H S Friedman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapyG Akabani, I Cokgor, R E Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
Pageof 2